Thrombolytic therapy efficacy in cardiopulmonary resuscitation: Investigating the effect of recombinant tissue plasminogen activator (Review)
Authors:
Open Access
- 1 October 2025
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 32 (6) , 1-14
Abstract
Cardiopulmonary resuscitation (CPR) involves a series of urgent life‑saving actions performed to manually revive a person in cardiac arrest. In >70% of CPR cases, the primary health deterioration is due to acute myocardial infarction or a significant pulmonary embolism. Fibrinolytic therapy, also known as thrombolytic treatment, functions by dissolving dangerous intravascular clots to mitigate ischemic damage through improved blood circulation. Thrombolytic therapy has emerged as a promising intervention within the context of CPR for patients experiencing cardiac arrest. Recombinant tissue plasminogen activator (rtPA) is a bioengineered version of a natural enzyme that converts plasminogen into plasmin, an enzyme essential for clot dissolution. The efficacy of rtPA in thrombolytic therapy for CPR suggests its potential as a valuable clinical tool. The present comprehensive review assessed the efficacy and safety of rtPA administration during CPR, focusing on outcomes such as survival rates, neurological function and potential complications. It also explored the underlying mechanisms by which rtPA may enhance reperfusion and improve patient outcomes, including clot dissolution, myocardial salvage and microcirculatory improvements. Additionally, it examined the optimal timing and dosing strategies for rtPA administration and its integration with standard CPR protocols and other supportive therapies.Keywords
This publication has 117 references indexed in Scilit:
- Use of recombinant tissue plasminogen activator (rTPA) for treatment of fibrin in the anterior chamber of the horseVeterinary Medicine and Science, 2024
- Long-term Survival After Out-of-Hospital Cardiac ArrestJAMA Cardiology, 2022
- Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic StrokeJAMA Network Open, 2022
- The Ethics and Laws Governing Informed Decision-Making in Healthcare: Informed Consent, Refusal, and Discussions Regarding Resuscitation and Life-Sustaining Treatment2021
- Assessing the quality of studies in meta‐research: Review/guidelines on the most important quality assessment toolsPharmaceutical Statistics, 2020
- Recombinant tissue plasminogen activators (rtPA): A reviewClinical Pharmacology & Therapeutics, 2015
- The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombiBiotechnology Progress, 2014
- Assessing Risk of Bias in Included Studies2008
- First Documented Rhythm and Clinical Outcome From In-Hospital Cardiac Arrest Among Children and AdultsJAMA, 2006
- In-Hospital Cardiopulmonary ResuscitationJAMA, 1988